Haemonetics Corp (HAE)
NYSE
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current HAE market cap is 3.41B. The company's latest EPS is USD 3.4906 and P/E is 20.37.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 343.29M | 336.17M | 345.51M | 348.54M | 330.6M |
| Operating Income | 27.94M | 39.76M | 51.7M | 44.93M | 50.61M |
| Net Income | 20.37M | 38.37M | 33.83M | 37.49M | 57.98M |
| Year End March 28 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 903.28M | 1B | 1.17B | 1.31B | 1.36B |
| Operating Income | 90.78M | 81.33M | 155.65M | 162.88M | 187M |
| Net Income | 79.47M | 43.38M | 115.4M | 117.56M | 167.68M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.2B | 2.54B | 2.53B | 2.53B | 2.45B |
| Total Liabilities | 1.24B | 1.64B | 1.65B | 1.62B | 1.63B |
| Total Equity | 959.96M | 905.37M | 878.85M | 906.86M | 820.84M |
| Year End March 28 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.82B | 1.86B | 1.93B | 2.2B | 2.45B |
| Total Liabilities | 1.09B | 1.11B | 1.12B | 1.24B | 1.63B |
| Total Equity | 731.67M | 749.42M | 818M | 959.96M | 820.84M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 181.75M | -27.42M | 21.4M | 65.17M | 181.73M |
| Investing | -322.39M | -139.2M | -162.56M | -179.94M | -161.9M |
| Financing | 38.16M | 333.69M | 258.89M | 260.27M | 108.82M |
| Year End March 28 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 108.81M | 172.26M | 273.06M | 181.75M | 181.73M |
| Investing | -425.44M | -86.35M | -143.79M | -322.39M | -161.9M |
| Financing | 367.45M | -15.75M | -100.36M | 38.16M | 108.82M |
| Market Cap | 3.41B |
| Price to Earnings Ratio | 20.37 |
| Price to Sales Ratio | 2.51 |
| Price to Cash Ratio | 11.14 |
| Price to Book Ratio | 4.16 |
| Dividend Yield | - |
| Shares Outstanding | 48.04M |
| Average Volume (1 week) | 554.29k |
| Average Volume (1 Month) | 538.3k |
| 52 Week Change | -16.55% |
| 52 Week High | 94.985 |
| 52 Week Low | 55.23 |
| Spread (Intraday) | 2.72 (3.76%) |
| Company Name | Haemonetics Corp |
| Address |
155 federal street boston, massachusetts 02110 |
| Website | https://www.haemonetics.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
